Ortho Evra is a birth control patch that has been on the market since 2002. However, in recent years, there have been concerns about the safety of this contraceptive method. This article will discuss the ortho evra recall and provide you with important information that you need to know.
The History of Ortho Evra Recall
In 2005, the U.S. Food and Drug Administration (FDA) issued a public health advisory regarding the use of Ortho Evra. The advisory warned that women using this birth control patch may be at a higher risk of developing blood clots compared to those using other hormonal contraceptives. The FDA also required the manufacturer of Ortho Evra, Johnson & Johnson, to update the product labeling to reflect this risk.
Following the FDA's advisory, a number of lawsuits were filed against Johnson & Johnson by women who claimed to have suffered serious health complications as a result of using Ortho Evra. These complications included deep vein thrombosis, pulmonary embolism, and stroke. As a result, Johnson & Johnson faced significant legal and financial consequences.
The Risks Associated with Ortho Evra
One of the main concerns with Ortho Evra is the increased risk of blood clots. Studies have shown that women using this birth control patch are twice as likely to develop blood clots compared to those using other hormonal contraceptives. This is because Ortho Evra delivers a higher dose of estrogen, which is known to increase the risk of blood clots.
In addition to blood clots, Ortho Evra has also been linked to other serious health complications. These include heart attack, stroke, and even death. It is important to note that while the overall risk of these complications is low, they are still a concern for women using Ortho Evra.
The Ortho Evra Recall
In 2008, Johnson & Johnson issued a voluntary recall of Ortho Evra. The recall was initiated due to concerns about the increased risk of blood clots associated with the use of this birth control patch. Johnson & Johnson stated that the recall was a precautionary measure to ensure the safety of women using Ortho Evra.
As a result of the recall, women who were using Ortho Evra were advised to consult with their healthcare providers to discuss alternative contraceptive options. The recall also led to a decline in the use of Ortho Evra and an increase in the use of other birth control methods.
The Importance of Being Informed
The ortho evra recall serves as a reminder of the importance of being informed about the risks and benefits of any medical treatment or contraceptive method. It is crucial for women to have access to accurate and up-to-date information so that they can make informed decisions about their reproductive health.
If you are currently using Ortho Evra or considering using it, it is important to discuss your options with your healthcare provider. They can provide you with the necessary information to make an informed decision about your contraceptive method.
Conclusion
The ortho evra recall highlights the potential risks associated with this birth control patch. While the overall risk of serious health complications is low, it is important for women to be aware of these risks and to discuss them with their healthcare providers. By being informed and making educated decisions, women can protect their reproductive health and choose the contraceptive method that is right for them.
Summary:
| Topic | Key Points |
|---|---|
| History of Ortho Evra Recall | - FDA issued a public health advisory in 2005 - Lawsuits filed against Johnson & Johnson - Updated product labeling required |
| Risks Associated with Ortho Evra | - Increased risk of blood clots - Other serious health complications - Higher dose of estrogen |
| Ortho Evra Recall | - Voluntary recall by Johnson & Johnson in 2008 - Precautionary measure - Decline in use of Ortho Evra |
| Importance of Being Informed | - Reminder to be informed about risks and benefits - Discuss options with healthcare provider - Make educated decisions |
